Despite the availability of antibiotics, the death rate from pneumonia in the U.S. has seen little improvement in the past…
MAINZ, Germany, July 24, 2023 (GLOBE NEWSWIRE) – BioNTech SE (Nasdaq: BNTX, “BioNTech” or “the Company”) will announce its financial…
Company to hold investor conference call on Monday, July 31, 2023 at 1:30 p.m. PT / 4:30 p.m. ETBRISBANE, Calif.,…
Tinlarebant (a/k/a LBS-008) is Belite Bio’s orally administered tablet intended to slow disease progression in patients with Stargardt Disease (STGD1)…
Continued calls for WHO resolution on self-careNYON, SWITZERLAND / ACCESSWIRE / July 24, 2023 / International Self-Care month 2023 opened…
Phase 3 study failed to meet one of the success criteria of the primary objectiveRSV program to be discontinuedCOPENHAGEN, Denmark,…
Financial Assistance From The Assistance Fund Now Available for Eligible People Living With Small Cell Lung CancerORLANDO, FL / ACCESSWIRE…
MEDELLÍN, COLOMBIA, ANTIOQUIA / ACCESSWIRE / July 22, 2023 / Situated in Medellin's prestigious "El Poblado," VeneersColombia.com stands out as…
CHICAGO, IL / ACCESSWIRE / July 21, 2023 / Cosmos Health Inc. (the "Company") (Nasdaq:COSM), a global healthcare group with…
SOUTHLAKE, TX / ACCESSWIRE / July 21, 2023 / Allied OMS - the country's only doctor-owned, doctor-led, and doctor-governed management…